| Literature DB >> 29434093 |
Naoki Yoneda1, Tadashi Takada1, Tetsushi Hirano2, Shogo Yanai1, Anzu Yamamoto1, Youhei Mantani3, Toshifumi Yokoyama1, Hiroshi Kitagawa3, Yoshiaki Tabuchi4, Nobuhiko Hoshi1.
Abstract
Although neonicotinoid pesticides are expected to have harmful influence on mammals, there is little animal experimental data to support the effect and mechanisms. Since acetylcholine causes the release of dopamine, neonicotinoids may confer a risk of developmental disorders via a disturbance in the monoamine systems. Male mice were peripubertally administered dinotefuran (DIN) referring to no observed effect level (NOEL) and performed behavioral and immunohistological analyses. In an open field test, the total locomotor activity was increased in a dose-dependent manner. The immunoreactivity of tyrosine hydroxylase in the substantia nigra was increased in DIN-exposed mice. These results suggest that exposure to DIN in peripubertal male mice causes hyperactivity and a disturbance of dopaminergic signaling.Entities:
Keywords: dinotefuran; dopamine; hyperactivity; neonicotinoid; neurobehavioral effect
Mesh:
Substances:
Year: 2018 PMID: 29434093 PMCID: PMC5938192 DOI: 10.1292/jvms.18-0014
Source DB: PubMed Journal: J Vet Med Sci ISSN: 0916-7250 Impact factor: 1.267
The combination of blocking agents and antibodies used for immunohistochemistry
| Detection | Blocking reagent | Primary antibody | Secondary antibody |
|---|---|---|---|
| TH | Blocking reagent A and B | Mouse monoclonal antibody against TH | Histofine MAX-PO (M) |
| (Nichirei Bioscience, Tokyo, Japan) | (MAB318; 1:5,000) | (Histofine Simplestain system) | |
| (Merck Millipore, Darmstadt, Germany) | (Nichirei Bioscience, Tokyo, Japan) | ||
| DRD1 | Blocking reagent A and B | Mouse monoclonal antibody against DRD1 | Histofine MAX-PO (M) |
| (Nichirei Bioscience, Tokyo, Japan) | (MAB5290; 1:1,500) | (Histofine Simplestain system) | |
| (Merck Millipore, Darmstadt, Germany) | (Nichirei Bioscience, Tokyo, Japan) | ||
| DRD2 | Blocking One Histo | Rabbit polyclonal antibody against DRD2 | EnVision + System- HRP Labeled Polymer |
| (Nacalai Tesque, Kyoto, Japan) | (AB5084P; 1:1,500) | Anti-Rabbit | |
| (Merck Millipore, Darmstadt, Germany) | (Dako, Glostrup, Denmark) | ||
TH: Tyrosine hydroxylase, DRD1: Dopamine receptor D1, DRD2: Dopamine receptor D2.
Fig. 1.Behavioral effects of peripubertal exposure to DIN on mouse behavior in an open field test and a Y-maze test. Total distances traveled were significantly increased in the DIN-2500 compared to the DIN-0 (A), but time spent in the center zone was not changed (B) in the open field test. There were no significant effects among all groups in the percentage of alternation behavior (C). Columns indicate the mean ± SE of each group and circles show the individual values of mice (n=6 in each), *P<0.05 by one-way ANOVA followed by Dunnett’s post-hoc test (A and B) or Kruskal-Wallis test followed by Steel’s post-hoc test (C).
Fig. 2.Representative immunohistochemistry for TH, DRD1 and DRD2 in sections of the mouse brain. In the substantia nigra, enhancement of the intensity of TH positivity was observed in the DIN exposure group (A–D). No significant effect on the intensity of TH positivity was observed in DRD1 (E–H) or DRD2 (I–L) of the striatum. Bar=100 µm (A–D), 500 µm (E–L).